Complementary use of gas chromatography–mass spectrometry, gas chromatography–atomic emission detection and nuclear magnetic resonance for identification of pharmaceutically related impurities of unknown structures
Krzysztof Łaniewski, Malin Vågerö, Egil Forsberg, Tobias Forngren, Gunnar HagmanVolume:
1027
Year:
2004
Language:
english
Pages:
10
DOI:
10.1016/j.chroma.2003.10.034
File:
PDF, 291 KB
english, 2004